Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dialysis01:27

Dialysis

314
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
314
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

162
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
162
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

95
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
95
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

89
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
89

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PCSK9 Inhibitors in Heart Transplant Recipients.

Transplantation proceedings·2026
Same author

Clinical Phenotypes in Heart Transplantation: Implications for Prognosis and Personalized Follow-up.

Transplantation·2026
Same author

Multiorgan failure and in-hospital mortality in urgent heart transplantation: the PRESAGIO study.

Revista espanola de cardiologia (English ed.)·2026
Same author

One-year multicenter prospective real-world study of vericiguat effectiveness and safety in Spain.

ESC heart failure·2026
Same author

Reply to Comment on "Combination of the Fibrosis-4 Index and Carbohydrate Antigen 125 to Predict Morbidity and Mortality in Acute Heart Failure".

Reviews in cardiovascular medicine·2026
Same author

Old donors for young heart transplant recipients: Clinical implications of an emerging phenomenon.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Related Experiment Video

Updated: Jul 4, 2025

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

16.0K

Practical Requirements for the Development of an Advanced Cardiorenal Unit.

Luis Almenar-Bonet1,2,3, Ignacio Sánchez-Lázaro1,2,3, Amparo Soldevila4,5

  • 1Heart Failure and Transplantation Unit, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Cardiorenal Medicine
|February 1, 2024
PubMed
Summary

Cardiorenal syndrome, the link between heart and kidney disease, requires specialized care. This study outlines the organizational needs for advanced cardiorenal units to improve patient management.

Keywords:
Advanced cardiorenal clinicsCardiorenal syndromeCardiorenal unitHeart failureKidney disease

More Related Videos

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.2K
Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.2K

Related Experiment Videos

Last Updated: Jul 4, 2025

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

16.0K
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.2K
Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
10:38

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies

Published on: January 16, 2019

20.2K

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Medicine

Background:

  • Heart failure and kidney disease frequently coexist, increasing patient morbidity and mortality.
  • The interplay between cardiac and renal dysfunction complicates treatment strategies.

Purpose of the Study:

  • To define the conditions and organizational characteristics necessary for establishing and advancing specialized cardiorenal units.
  • To provide a framework for the development and continuous improvement of these units.

Main Methods:

  • This study addresses the organizational and strategic requirements for advanced cardiorenal units.
  • It necessitates a multilevel action plan encompassing governance, patient selection, staffing, services, care processes, and information systems.

Main Results:

  • The creation of specialized cardiorenal units requires a comprehensive, multidisciplinary approach.
  • An advanced cardiorenal unit model is proposed to manage complex and critical cardiorenal syndrome cases.
  • Continuous evaluation using specific indicators is crucial for identifying areas for improvement.

Conclusions:

  • Specialized cardiorenal units are essential for rigorous and personalized management of cardiorenal syndrome.
  • Developing these units presents a significant challenge requiring a structured action plan.
  • The proposed framework supports the creation, development, and ongoing enhancement of advanced cardiorenal units.